The Neurostimulation Devices Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2011-2022) and extends its insights into a ten-year forecast period (2024-2033).
Learn More On The Neurostimulation Devices Market:
https://www.thebusinessresearchcompany.com/report/neurostimulation-devices-global-market-report
According to The Business Research Company’s Neurostimulation Devices Global Market Report 2024, The neurostimulation devices market size has grown rapidly in recent years. It will grow from $6.34 billion in 2023 to $6.98 billion in 2024 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to chronic pain management, aging population, awareness and acceptance, multidisciplinary approach.
The neurostimulation devices market size is expected to see strong growth in the next few years. It will grow to $10.12 billion in 2028 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to minimally invasive techniques, emerging markets growth, regulatory support and reimbursement, telehealth and remote monitoring. Major trends in the forecast period include personalized therapy, wearable neurostimulation devices, advanced programming and connectivity, combination therapies.
The rising geriatric population across the globe is driving the growth of the neurostimulation device market. An increasing number of the population is aging, and this geriatric population is falling prey to different neurobiological disorders. For instance, in October 2022, WHO, a specialized agency of the United Nations responsible for international public health stated that in 2050, 80% of older people will be living in low- and middle-income countries. Between 2015 and 2050, the proportion of the world’s population over 60 years will nearly double from 12% to 22%.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=3549&type=smp
The neurostimulation devices market covered in this report is segmented –
1) By Product: Implantable Devices; External Devices
2) By Application: Pain Management; Epilepsy; Essential Tremor; Urinary and Fecal Incontinence; Depression; Dystonia; Gastroparesis; Parkinson’s Disease
3) By End User: Hospitals; Rehabilitation Centers; Medical Clinic
Sub-Segments Covered:
By Implantable Devices: Cochlear Implants; Deep Brain Stimulation; Spinal Cord Stimulation; Vagus Nerve Stimulation; Sacral Nerve Stimulation; Gastric Electric Stimulation 5) By External Devices: Transcranial Magnetic Stimulation (TMS); Transcutaneous Electrical Nerve Stimulation (TENS)
The neurostimulation devices market report table of contents includes:
1. Executive Summary
2. Market Characteristics
3. Market Trends And Strategies
4. Impact Of COVID-19
5. Market Size And Growth
6. Segmentation
7. Regional And Country Analysis
.
.
.
27. Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
